Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for August 6th

Read MoreHide Full Article

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 6th:

Norbord Inc. : This manufacturer and seller of wood-based panels has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Norbord Inc. Price and Consensus

Norbord's shares gained 30.1% over the last one month compared to S&P 500’s rise of 6.2%. The company possesses a Momentum Score of B.

Norbord Inc. Price

Verona Pharma plc (VRNA - Free Report) : This clinical stage biopharmaceutical company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 62.2% over the last 60 days.

Verona Pharma PLC American Depositary Share Price and Consensus

Verona's shares gained 45.2% over the last one month. The company possesses a Momentum Score of B.

Verona Pharma PLC American Depositary Share Price

Plantronics, Inc. : This designer and seller of integrated communications and collaborations solutions has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.6% over the last 60 days.

Plantronics, Inc. Price and Consensus

Plantronics' shares gained 26.7% over the last one month. The company possesses a Momentum Score of A.

Plantronics, Inc. Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

More Stock News: This Is Bigger than the iPhone!

It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.

Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2021.

Click here for the 6 trades >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Verona Pharma PLC American Depositary Share (VRNA) - free report >>

Published in